Express News | Celularity : Intend to File Form 10-Q for Q2 2024 Within Coming Weeks

BreakingsOct 22 20:35

Celularity Provides Corporate Update; Says The Acquisition Of Rebound Adds To Our Portfolio Of Placental-Derived Advanced Biomaterial Products, Sales Of Which Through The First Half Of 2024 Were In Excess Of $24M; Guidance Of Expected Combined Net...

BenzingaOct 22 20:33

Express News | Celularity Provides Corporate Update

BreakingsOct 22 20:30

Sector Update: Health Care Stocks Fall Late Afternoon

MT NewswiresOct 22 04:01

Celularity Inc. Receives Notice From Nasdaq; Confirms Intention to File an Appeal

GlobeNewswireOct 19 06:00

10-Q: Q1 2024 Earnings Report

SECOct 17 05:28 · Announcements